BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 5, 2005
View Archived Issues
Activation of mGlu4 receptors - a pharmacological strategy against medulloblastoma
Read More
Hypoglycemic effects of FR-225654 in preclinical models of diabetes
Read More
Pimecrolimus reported effective in facial seborrheic dermatitis
Read More
Amarillo updates low dose oral interferon progress
Read More
A novel bimosiamose formulation reduces plaque thickness in psoriasis
Read More
NeoPharm establishes bioequivalence for LEP-ETU
Read More
LigoCyte receives NIH grant for intranasal anthrax vaccine
Read More
Positive results of phase III trial of oxymorphone ER
Read More
Genaissance enters into HAP technology license agreement with Sankyo
Read More
Phase II program cleared for cholesterol-lowering drug FM-VP4
Read More
Acadia receives milestone under Allergan collaboration
Read More
Allergan and GSK enter product agreements
Read More
Japanese National Institute of Infectious Diseases to study Ampligen
Read More
AVR-118 begins phase I study in type 2 diabetes patients
Read More
Barbeau Pharma progresses pipeline
Read More
EGF/gastrin combination, E1-INT, reverses hyperglycemia and increases beta-cell mass
Read More
CTB-Insulin oral vaccine produced in silkworm larvae protects NOD mice from autoimmune diabetes
Read More
Anti-IL-13 antibody (CAT-354) effective against allergic airway and esophageal inflammation in mice
Read More
Data on novel SERM LY-2066948.HCl
Read More
Stockholders of Salix and InKine approve merger
Read More
Five reports of Guillain-Barre syndrome following administration of Menactra
Read More
Oracea NDA submission accepted for review
Read More
Discontinuation of phase III Canvaxin study in stage III melanoma
Read More
European approval for Vasovist for magnetic resonance angiography
Read More
Update on the antiepileptic effects of adjunctive rufinamide
Read More
Antipsychotics demonstrate similar efficacy in schizophrenia patients
Read More
Intralesional bleomycin plus electroporation under evaluation for metastatic melanoma
Read More
Recent patents disclose novel analgesic agents
Read More
New antiinfective agents described in recent patents
Read More
New anticoagulants prepared and tested by Aventis
Read More